US Stock MarketDetailed Quotes

CTNM Contineum Therapeutics

Watchlist
  • 16.110
  • +0.250+1.58%
Trading May 23 15:33 ET
414.40MMarket Cap-124883P/E (TTM)

Contineum Therapeutics Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Apr 30, 2024

Based on 3 analysts giving stock ratings to Contineum Therapeutics in the past 3 months

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

Updated: Apr 30, 2024

The average Contineum Therapeutics stock price target is 28.00 with a max estimate of 30.00 and a min estimate of 25.00

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Analysis

Analyst Rating

Updated: Apr 30, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

Updated: Apr 30, 2024

Heat List
US
Overall
Symbol
Latest Price
%Chg